Hosch S, Wagner P, Giger J.N, Dubach N, Saavedra E, Perno C.F, Gody J.C, Pagonendji M.S, Ngoagouni C, Ndoua C, Nsanzabana C, Vickos U, Daubenberger C, Schindler T. PHARE: a bioinformatics pipeline for compositional profiling of multiclonal Plasmodium falciparum infections from long-read Nanopore sequencing data. J Antimicrob Chemother. 2024(in press). DOI: 10.1093/jac/dkae060

2024
Journal Article
PubMed

Bechtold P, Wagner P, Hosch S, Gregorini M, Stark W.J, Gody J.C, Kodia-Lenguetama E.R, Pagonendji M.S, Donfack O.T, Phiri W.P, GarcĂ­a G.A, Nsanzabana C, Daubenberger C.A, Schindler T, Vickos U. Development and evaluation of PlasmoPod: a cartridge-based nucleic acid amplification test for rapid malaria diagnosis and surveillance. PLOS Glob Public Health. 2023;3(9):e0001516. DOI: 10.1371/journal.pgph.0001516

2023
Journal Article
PubMed

Golumbeanu M, Edi C.A.V, Hetzel M.W, Koepfli C, Nsanzabana C. Bridging the gap from molecular surveillance to programmatic decisions for malaria control and elimination. Am J Trop Med Hyg. 2023(in press). DOI: 10.4269/ajtmh.22-0749

2023
Journal Article
PubMed

Nsanzabana C. Time to scale up molecular surveillance for anti-malarial drug resistance in sub-Saharan Africa. Malar J. 2021;20:401. DOI: 10.1186/s12936-021-03942-5

2021
Journal Article
PubMed

Nsanzabana C. Resistance to Artemisinin Combination Therapies (ACTs): do not forget the partner drug!. Trop Med Infect Dis. 2019;4(1):26. DOI: 10.3390/tropicalmed4010026

2019
Journal Article
PubMed

Nsanzabana C. Strengthening surveillance systems for malaria elimination by integrating molecular and genomic data. Trop Med Infect Dis. 2019;4:139. DOI: 10.3390/tropicalmed4040139

2019
Journal Article
PubMed

WorldWide Antimalarial Resistance Network (WWARN) - AS-AQ Study Group. The effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of individual patient data. BMC Med. 2015;13:66. DOI: 10.1186/s12916-015-0301-z

2015
Journal Article
PubMed

WWARN Artemisinin based Combination Therapy (ACT) Africa Baseline Study Group. Clinical determinants of early parasitological response to ACTs in African patients with uncomplicated falciparum malaria: a literature review and meta-analysis of individual patient data. BMC Med. 2015;13:212. DOI: 10.1186/s12916-015-0445-x

2015
Journal Article
PubMed